Global Invasive Fungal Infection Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 235869
  • calendar_today Published On: Dec, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Invasive Fungal Infection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Invasive Fungal Infection size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Invasive Fungal Infection market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Invasive Fungal Infection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Diagnosis

Treatment

Market segment by Application, can be divided into

Yeast-like Fungi

Filamentous Fungi

Other

Market segment by players, this report covers

Cidara Therapeutics

Basilea Pharmaceutica

Pfizer

GlaxoSmithKline

Bayer

Abbott

Merck

Astellas Pharma

F2G

Scynexis

Associates of Cape Cod

BioRad

IMMY

Beijing Jinshanchuan

Danna Biological

Zhanjiang A and C Biological

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Invasive Fungal Infection product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Invasive Fungal Infection, with revenue, gross margin and global market share of Invasive Fungal Infection from 2019 to 2021.

Chapter 3, the Invasive Fungal Infection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Invasive Fungal Infection market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Invasive Fungal Infection research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Invasive Fungal Infection

1.2 Classification of Invasive Fungal Infection by Type

1.2.1 Overview: Global Invasive Fungal Infection Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Invasive Fungal Infection Revenue Market Share by Type in 2020

1.2.3 Diagnosis

1.2.4 Treatment

1.3 Global Invasive Fungal Infection Market by Application

1.3.1 Overview: Global Invasive Fungal Infection Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Yeast-like Fungi

1.3.3 Filamentous Fungi

1.3.4 Other

1.4 Global Invasive Fungal Infection Market Size & Forecast

1.5 Global Invasive Fungal Infection Market Size and Forecast by Region

1.5.1 Global Invasive Fungal Infection Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Invasive Fungal Infection Market Size by Region, (2016-2021)

1.5.3 North America Invasive Fungal Infection Market Size and Prospect (2016-2026)

1.5.4 Europe Invasive Fungal Infection Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Invasive Fungal Infection Market Size and Prospect (2016-2026)

1.5.6 South America Invasive Fungal Infection Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Invasive Fungal Infection Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Invasive Fungal Infection Market Drivers

1.6.2 Invasive Fungal Infection Market Restraints

1.6.3 Invasive Fungal Infection Trends Analysis

2 Company Profiles

2.1 Cidara Therapeutics

2.1.1 Cidara Therapeutics Details

2.1.2 Cidara Therapeutics Major Business

2.1.3 Cidara Therapeutics Invasive Fungal Infection Product and Solutions

2.1.4 Cidara Therapeutics Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Cidara Therapeutics Recent Developments and Future Plans

2.2 Basilea Pharmaceutica

2.2.1 Basilea Pharmaceutica Details

2.2.2 Basilea Pharmaceutica Major Business

2.2.3 Basilea Pharmaceutica Invasive Fungal Infection Product and Solutions

2.2.4 Basilea Pharmaceutica Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Basilea Pharmaceutica Recent Developments and Future Plans

2.3 Pfizer

2.3.1 Pfizer Details

2.3.2 Pfizer Major Business

2.3.3 Pfizer Invasive Fungal Infection Product and Solutions

2.3.4 Pfizer Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Pfizer Recent Developments and Future Plans

2.4 GlaxoSmithKline

2.4.1 GlaxoSmithKline Details

2.4.2 GlaxoSmithKline Major Business

2.4.3 GlaxoSmithKline Invasive Fungal Infection Product and Solutions

2.4.4 GlaxoSmithKline Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 GlaxoSmithKline Recent Developments and Future Plans

2.5 Bayer

2.5.1 Bayer Details

2.5.2 Bayer Major Business

2.5.3 Bayer Invasive Fungal Infection Product and Solutions

2.5.4 Bayer Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Bayer Recent Developments and Future Plans

2.6 Abbott

2.6.1 Abbott Details

2.6.2 Abbott Major Business

2.6.3 Abbott Invasive Fungal Infection Product and Solutions

2.6.4 Abbott Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Abbott Recent Developments and Future Plans

2.7 Merck

2.7.1 Merck Details

2.7.2 Merck Major Business

2.7.3 Merck Invasive Fungal Infection Product and Solutions

2.7.4 Merck Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Merck Recent Developments and Future Plans

2.8 Astellas Pharma

2.8.1 Astellas Pharma Details

2.8.2 Astellas Pharma Major Business

2.8.3 Astellas Pharma Invasive Fungal Infection Product and Solutions

2.8.4 Astellas Pharma Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Astellas Pharma Recent Developments and Future Plans

2.9 F2G

2.9.1 F2G Details

2.9.2 F2G Major Business

2.9.3 F2G Invasive Fungal Infection Product and Solutions

2.9.4 F2G Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 F2G Recent Developments and Future Plans

2.10 Scynexis

2.10.1 Scynexis Details

2.10.2 Scynexis Major Business

2.10.3 Scynexis Invasive Fungal Infection Product and Solutions

2.10.4 Scynexis Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Scynexis Recent Developments and Future Plans

2.11 Associates of Cape Cod

2.11.1 Associates of Cape Cod Details

2.11.2 Associates of Cape Cod Major Business

2.11.3 Associates of Cape Cod Invasive Fungal Infection Product and Solutions

2.11.4 Associates of Cape Cod Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Associates of Cape Cod Recent Developments and Future Plans

2.12 BioRad

2.12.1 BioRad Details

2.12.2 BioRad Major Business

2.12.3 BioRad Invasive Fungal Infection Product and Solutions

2.12.4 BioRad Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 BioRad Recent Developments and Future Plans

2.13 IMMY

2.13.1 IMMY Details

2.13.2 IMMY Major Business

2.13.3 IMMY Invasive Fungal Infection Product and Solutions

2.13.4 IMMY Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 IMMY Recent Developments and Future Plans

2.14 Beijing Jinshanchuan

2.14.1 Beijing Jinshanchuan Details

2.14.2 Beijing Jinshanchuan Major Business

2.14.3 Beijing Jinshanchuan Invasive Fungal Infection Product and Solutions

2.14.4 Beijing Jinshanchuan Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Beijing Jinshanchuan Recent Developments and Future Plans

2.15 Danna Biological

2.15.1 Danna Biological Details

2.15.2 Danna Biological Major Business

2.15.3 Danna Biological Invasive Fungal Infection Product and Solutions

2.15.4 Danna Biological Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Danna Biological Recent Developments and Future Plans

2.16 Zhanjiang A and C Biological

2.16.1 Zhanjiang A and C Biological Details

2.16.2 Zhanjiang A and C Biological Major Business

2.16.3 Zhanjiang A and C Biological Invasive Fungal Infection Product and Solutions

2.16.4 Zhanjiang A and C Biological Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Zhanjiang A and C Biological Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Invasive Fungal Infection Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Invasive Fungal Infection Players Market Share

3.2.2 Top 10 Invasive Fungal Infection Players Market Share

3.2.3 Market Competition Trend

3.3 Invasive Fungal Infection Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Invasive Fungal Infection Revenue and Market Share by Type (2016-2021)

4.2 Global Invasive Fungal Infection Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Invasive Fungal Infection Revenue Market Share by Application (2016-2021)

5.2 Invasive Fungal Infection Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Invasive Fungal Infection Revenue by Type (2016-2026)

6.2 North America Invasive Fungal Infection Revenue by Application (2016-2026)

6.3 North America Invasive Fungal Infection Market Size by Country

6.3.1 North America Invasive Fungal Infection Revenue by Country (2016-2026)

6.3.2 United States Invasive Fungal Infection Market Size and Forecast (2016-2026)

6.3.3 Canada Invasive Fungal Infection Market Size and Forecast (2016-2026)

6.3.4 Mexico Invasive Fungal Infection Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Invasive Fungal Infection Revenue by Type (2016-2026)

7.2 Europe Invasive Fungal Infection Revenue by Application (2016-2026)

7.3 Europe Invasive Fungal Infection Market Size by Country

7.3.1 Europe Invasive Fungal Infection Revenue by Country (2016-2026)

7.3.2 Germany Invasive Fungal Infection Market Size and Forecast (2016-2026)

7.3.3 France Invasive Fungal Infection Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Invasive Fungal Infection Market Size and Forecast (2016-2026)

7.3.5 Russia Invasive Fungal Infection Market Size and Forecast (2016-2026)

7.3.6 Italy Invasive Fungal Infection Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Invasive Fungal Infection Revenue by Type (2016-2026)

8.2 Asia-Pacific Invasive Fungal Infection Revenue by Application (2016-2026)

8.3 Asia-Pacific Invasive Fungal Infection Market Size by Region

8.3.1 Asia-Pacific Invasive Fungal Infection Revenue by Region (2016-2026)

8.3.2 China Invasive Fungal Infection Market Size and Forecast (2016-2026)

8.3.3 Japan Invasive Fungal Infection Market Size and Forecast (2016-2026)

8.3.4 South Korea Invasive Fungal Infection Market Size and Forecast (2016-2026)

8.3.5 India Invasive Fungal Infection Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Invasive Fungal Infection Market Size and Forecast (2016-2026)

8.3.7 Australia Invasive Fungal Infection Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Invasive Fungal Infection Revenue by Type (2016-2026)

9.2 South America Invasive Fungal Infection Revenue by Application (2016-2026)

9.3 South America Invasive Fungal Infection Market Size by Country

9.3.1 South America Invasive Fungal Infection Revenue by Country (2016-2026)

9.3.2 Brazil Invasive Fungal Infection Market Size and Forecast (2016-2026)

9.3.3 Argentina Invasive Fungal Infection Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Invasive Fungal Infection Revenue by Type (2016-2026)

10.2 Middle East & Africa Invasive Fungal Infection Revenue by Application (2016-2026)

10.3 Middle East & Africa Invasive Fungal Infection Market Size by Country

10.3.1 Middle East & Africa Invasive Fungal Infection Revenue by Country (2016-2026)

10.3.2 Turkey Invasive Fungal Infection Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Invasive Fungal Infection Market Size and Forecast (2016-2026)

10.3.4 UAE Invasive Fungal Infection Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Invasive Fungal Infection Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Invasive Fungal Infection Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Invasive Fungal Infection Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Invasive Fungal Infection Revenue (USD Million) by Region (2016-2021)

Table 5. Global Invasive Fungal Infection Revenue Market Share by Region (2021-2026)

Table 6. Cidara Therapeutics Corporate Information, Head Office, and Major Competitors

Table 7. Cidara Therapeutics Major Business

Table 8. Cidara Therapeutics Invasive Fungal Infection Product and Solutions

Table 9. Cidara Therapeutics Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Basilea Pharmaceutica Corporate Information, Head Office, and Major Competitors

Table 11. Basilea Pharmaceutica Major Business

Table 12. Basilea Pharmaceutica Invasive Fungal Infection Product and Solutions

Table 13. Basilea Pharmaceutica Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Pfizer Corporate Information, Head Office, and Major Competitors

Table 15. Pfizer Major Business

Table 16. Pfizer Invasive Fungal Infection Product and Solutions

Table 17. Pfizer Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 19. GlaxoSmithKline Major Business

Table 20. GlaxoSmithKline Invasive Fungal Infection Product and Solutions

Table 21. GlaxoSmithKline Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Bayer Corporate Information, Head Office, and Major Competitors

Table 23. Bayer Major Business

Table 24. Bayer Invasive Fungal Infection Product and Solutions

Table 25. Bayer Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Abbott Corporate Information, Head Office, and Major Competitors

Table 27. Abbott Major Business

Table 28. Abbott Invasive Fungal Infection Product and Solutions

Table 29. Abbott Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Merck Corporate Information, Head Office, and Major Competitors

Table 31. Merck Major Business

Table 32. Merck Invasive Fungal Infection Product and Solutions

Table 33. Merck Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 35. Astellas Pharma Major Business

Table 36. Astellas Pharma Invasive Fungal Infection Product and Solutions

Table 37. Astellas Pharma Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. F2G Corporate Information, Head Office, and Major Competitors

Table 39. F2G Major Business

Table 40. F2G Invasive Fungal Infection Product and Solutions

Table 41. F2G Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Scynexis Corporate Information, Head Office, and Major Competitors

Table 43. Scynexis Major Business

Table 44. Scynexis Invasive Fungal Infection Product and Solutions

Table 45. Scynexis Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Associates of Cape Cod Corporate Information, Head Office, and Major Competitors

Table 47. Associates of Cape Cod Major Business

Table 48. Associates of Cape Cod Invasive Fungal Infection Product and Solutions

Table 49. Associates of Cape Cod Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. BioRad Corporate Information, Head Office, and Major Competitors

Table 51. BioRad Major Business

Table 52. BioRad Invasive Fungal Infection Product and Solutions

Table 53. BioRad Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. IMMY Corporate Information, Head Office, and Major Competitors

Table 55. IMMY Major Business

Table 56. IMMY Invasive Fungal Infection Product and Solutions

Table 57. IMMY Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Beijing Jinshanchuan Corporate Information, Head Office, and Major Competitors

Table 59. Beijing Jinshanchuan Major Business

Table 60. Beijing Jinshanchuan Invasive Fungal Infection Product and Solutions

Table 61. Beijing Jinshanchuan Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Danna Biological Corporate Information, Head Office, and Major Competitors

Table 63. Danna Biological Major Business

Table 64. Danna Biological Invasive Fungal Infection Product and Solutions

Table 65. Danna Biological Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Zhanjiang A and C Biological Corporate Information, Head Office, and Major Competitors

Table 67. Zhanjiang A and C Biological Major Business

Table 68. Zhanjiang A and C Biological Invasive Fungal Infection Product and Solutions

Table 69. Zhanjiang A and C Biological Invasive Fungal Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Global Invasive Fungal Infection Revenue (USD Million) by Players (2019-2021)

Table 71. Global Invasive Fungal Infection Revenue Share by Players (2019-2021)

Table 72. Breakdown of Invasive Fungal Infection by Company Type (Tier 1, Tier 2 and Tier 3)

Table 73. Invasive Fungal Infection Players Head Office, Products and Services Provided

Table 74. Invasive Fungal Infection Mergers & Acquisitions in the Past Five Years

Table 75. Invasive Fungal Infection New Entrants and Expansion Plans

Table 76. Global Invasive Fungal Infection Revenue (USD Million) by Type (2016-2021)

Table 77. Global Invasive Fungal Infection Revenue Share by Type (2016-2021)

Table 78. Global Invasive Fungal Infection Revenue Forecast by Type (2021-2026)

Table 79. Global Invasive Fungal Infection Revenue by Application (2016-2021)

Table 80. Global Invasive Fungal Infection Revenue Forecast by Application (2021-2026)

Table 81. North America Invasive Fungal Infection Revenue by Type (2016-2021) & (USD Million)

Table 82. North America Invasive Fungal Infection Revenue by Type (2021-2026) & (USD Million)

Table 83. North America Invasive Fungal Infection Revenue by Application (2016-2021) & (USD Million)

Table 84. North America Invasive Fungal Infection Revenue by Application (2021-2026) & (USD Million)

Table 85. North America Invasive Fungal Infection Revenue by Country (2016-2021) & (USD Million)

Table 86. North America Invasive Fungal Infection Revenue by Country (2021-2026) & (USD Million)

Table 87. Europe Invasive Fungal Infection Revenue by Type (2016-2021) & (USD Million)

Table 88. Europe Invasive Fungal Infection Revenue by Type (2021-2026) & (USD Million)

Table 89. Europe Invasive Fungal Infection Revenue by Application (2016-2021) & (USD Million)

Table 90. Europe Invasive Fungal Infection Revenue by Application (2021-2026) & (USD Million)

Table 91. Europe Invasive Fungal Infection Revenue by Country (2016-2021) & (USD Million)

Table 92. Europe Invasive Fungal Infection Revenue by Country (2021-2026) & (USD Million)

Table 93. Asia-Pacific Invasive Fungal Infection Revenue by Type (2016-2021) & (USD Million)

Table 94. Asia-Pacific Invasive Fungal Infection Revenue by Type (2021-2026) & (USD Million)

Table 95. Asia-Pacific Invasive Fungal Infection Revenue by Application (2016-2021) & (USD Million)

Table 96. Asia-Pacific Invasive Fungal Infection Revenue by Application (2021-2026) & (USD Million)

Table 97. Asia-Pacific Invasive Fungal Infection Revenue by Region (2016-2021) & (USD Million)

Table 98. Asia-Pacific Invasive Fungal Infection Revenue by Region (2021-2026) & (USD Million)

Table 99. South America Invasive Fungal Infection Revenue by Type (2016-2021) & (USD Million)

Table 100. South America Invasive Fungal Infection Revenue by Type (2021-2026) & (USD Million)

Table 101. South America Invasive Fungal Infection Revenue by Application (2016-2021) & (USD Million)

Table 102. South America Invasive Fungal Infection Revenue by Application (2021-2026) & (USD Million)

Table 103. South America Invasive Fungal Infection Revenue by Country (2016-2021) & (USD Million)

Table 104. South America Invasive Fungal Infection Revenue by Country (2021-2026) & (USD Million)

Table 105. Middle East & Africa Invasive Fungal Infection Revenue by Type (2016-2021) & (USD Million)

Table 106. Middle East & Africa Invasive Fungal Infection Revenue by Type (2021-2026) & (USD Million)

Table 107. Middle East & Africa Invasive Fungal Infection Revenue by Application (2016-2021) & (USD Million)

Table 108. Middle East & Africa Invasive Fungal Infection Revenue by Application (2021-2026) & (USD Million)

Table 109. Middle East & Africa Invasive Fungal Infection Revenue by Country (2016-2021) & (USD Million)

Table 110. Middle East & Africa Invasive Fungal Infection Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Invasive Fungal Infection Picture

Figure 2. Global Invasive Fungal Infection Revenue Market Share by Type in 2020

Figure 3. Diagnosis

Figure 4. Treatment

Figure 5. Invasive Fungal Infection Revenue Market Share by Application in 2020

Figure 6. Yeast-like Fungi Picture

Figure 7. Filamentous Fungi Picture

Figure 8. Other Picture

Figure 9. Global Invasive Fungal Infection Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Invasive Fungal Infection Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Invasive Fungal Infection Revenue Market Share by Region (2016-2026)

Figure 12. Global Invasive Fungal Infection Revenue Market Share by Region in 2020

Figure 13. North America Invasive Fungal Infection Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Invasive Fungal Infection Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Invasive Fungal Infection Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Invasive Fungal Infection Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Invasive Fungal Infection Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Invasive Fungal Infection Market Drivers

Figure 19. Invasive Fungal Infection Market Restraints

Figure 20. Invasive Fungal Infection Market Trends

Figure 21. Cidara Therapeutics Recent Developments and Future Plans

Figure 22. Basilea Pharmaceutica Recent Developments and Future Plans

Figure 23. Pfizer Recent Developments and Future Plans

Figure 24. GlaxoSmithKline Recent Developments and Future Plans

Figure 25. Bayer Recent Developments and Future Plans

Figure 26. Abbott Recent Developments and Future Plans

Figure 27. Merck Recent Developments and Future Plans

Figure 28. Astellas Pharma Recent Developments and Future Plans

Figure 29. F2G Recent Developments and Future Plans

Figure 30. Scynexis Recent Developments and Future Plans

Figure 31. Associates of Cape Cod Recent Developments and Future Plans

Figure 32. BioRad Recent Developments and Future Plans

Figure 33. IMMY Recent Developments and Future Plans

Figure 34. Beijing Jinshanchuan Recent Developments and Future Plans

Figure 35. Danna Biological Recent Developments and Future Plans

Figure 36. Zhanjiang A and C Biological Recent Developments and Future Plans

Figure 37. Global Invasive Fungal Infection Revenue Share by Players in 2020

Figure 38. Invasive Fungal Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 39. Global Top 3 Players Invasive Fungal Infection Revenue Market Share in 2020

Figure 40. Global Top 10 Players Invasive Fungal Infection Revenue Market Share in 2020

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 42. Global Invasive Fungal Infection Revenue Share by Type in 2020

Figure 43. Global Invasive Fungal Infection Market Share Forecast by Type (2021-2026)

Figure 44. Global Invasive Fungal Infection Revenue Share by Application in 2020

Figure 45. Global Invasive Fungal Infection Market Share Forecast by Application (2021-2026)

Figure 46. North America Invasive Fungal Infection Sales Market Share by Type (2016-2026)

Figure 47. North America Invasive Fungal Infection Sales Market Share by Application (2016-2026)

Figure 48. North America Invasive Fungal Infection Revenue Market Share by Country (2016-2026)

Figure 49. United States Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Canada Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Mexico Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Europe Invasive Fungal Infection Sales Market Share by Type (2016-2026)

Figure 53. Europe Invasive Fungal Infection Sales Market Share by Application (2016-2026)

Figure 54. Europe Invasive Fungal Infection Revenue Market Share by Country (2016-2026)

Figure 55. Germany Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. France Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. United Kingdom Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Russia Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Italy Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Asia-Pacific Invasive Fungal Infection Sales Market Share by Type (2016-2026)

Figure 61. Asia-Pacific Invasive Fungal Infection Sales Market Share by Application (2016-2026)

Figure 62. Asia-Pacific Invasive Fungal Infection Revenue Market Share by Region (2016-2026)

Figure 63. China Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Japan Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South Korea Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. India Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Southeast Asia Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Australia Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South America Invasive Fungal Infection Sales Market Share by Type (2016-2026)

Figure 70. South America Invasive Fungal Infection Sales Market Share by Application (2016-2026)

Figure 71. South America Invasive Fungal Infection Revenue Market Share by Country (2016-2026)

Figure 72. Brazil Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Argentina Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Middle East and Africa Invasive Fungal Infection Sales Market Share by Type (2016-2026)

Figure 75. Middle East and Africa Invasive Fungal Infection Sales Market Share by Application (2016-2026)

Figure 76. Middle East and Africa Invasive Fungal Infection Revenue Market Share by Country (2016-2026)

Figure 77. Turkey Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Saudi Arabia Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. UAE Invasive Fungal Infection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source